Moderna Clears $258 to Set a Fresh 52-Week High
As seen on the 24/7 Wall St. homepage on November 4, 2026.
Moderna cleared $258.38, a fresh 52-week high and 5.11% above the peak it set on October 21. The $103.2 billion vaccine maker keeps resetting its own ceiling faster than two weeks at a time.
Continue ReadingShow less
Moderna's stock reached $258.38 on November 4, clearing a 52-week high that sits 5.11% above the previous peak set on October 21. That prior record was itself recent, which means the stock has been resetting its own ceiling in a matter of weeks rather than months.
Shares traded as low as the $23 to $62 range for much of the past year before this climb, making the current level a sharp break from that base.
Sponsored
A 52-week high at this pace draws momentum-focused funds, which sustain buying pressure while the move holds.
The speed of this run matters as much as the level: resetting a 52-week high just two weeks after the last one shows demand outpacing prior valuations, leaving sidelined investors further behind with each record.
Sources
Mentioned: MRNA